Successful persistent strabismic amblyopia treatment using active therapy as an adjuvant to occlusion
Journal of Optometry · 2025
DOI: 10.1016/j.optom.2025.100557 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Optometry, 2025. Verfasst von Irene Sanchez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Física Teórica, Atómica y Óptica, Universidad de Valladolid, Valladolid, Spain; Optometry Research Group, IOBA Eye Institute, Univers…. Hauptthemen laut MEDLINE: Amblyopia, Strabismus, Sensory Deprivation, Orthoptics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Universidad de Oviedo, Universidad de Valladolid.
Abstract (Originalsprache)
PURPOSE: A novel protocol to improve long-term results in the treatment of amblyopia was proposed. The protocol combines active home-based therapy through perceptual learning activities (Gabor patch, dichoptic stimulation, and random dot stereograms) with conventional visual therapy in the clinic as an adjunct to patching occlusion in subjects with patch-resistant amblyopia METHODS: Between 2018 and 2022, a group of patients received treatment for persistent strabismic and combined-mechanism amblyopia according to the novel treatment protocol, consisting of in-clinic orthoptics/visual therapy combined with the use of gamified PL software at home, as an adjunct to occlusion treatment. RESULTS: A retrospective analysis of treatment outcomes was subsequently carried out for 53 patients aged 7.75±5.88. Eccentric fixation was present in 17 of the 53 subjects. The distribution of patients presenting with combined-mechanism and strabismic amblyopia was 37 and 16, respectively. Eighteen patients (34 %) demonstrated measurable stereoacuity prior to treatment. Following treatment using the combined treatment protocol, forty-six (87 %) participants achieved a of logMAR 0.1 or better, mean BCVA was significantly improved, from logMAR 0.30±0.23 to logMAR 0.07±0.12 (p < 0.01). Eleven subjects (65 %) of seventeen participants with eccentric fixation achieved central fixation. In addition, stereoacuity was measurable in 43 patients (81 %). Mean stereoacuity improved, from 1200.00±258.69 arc seconds to 539.62±518.69 arc seconds (p < 0.01). These results remained stable six months after completion of the therapy. CONCLUSION: The outcomes of the proposed novel treatment protocol were reduced angle of deviation, and improved BCVA and stereoacuity in patients with persistent strabismic and combined-mechanism amblyopia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento de Física Teórica, Atómica y Óptica, Universidad de Valladolid, Valladolid, Spain; Optometry Research Group, IOBA Eye Institute, University of Valladolid, Valladolid, Spain. Electronic address: irene.sanche…
- Department of Construction and Manufacturing Engineering, University of Oviedo, Asturias, Spain.
- Department of Optometry, Begira Ophthalmologic Clinic, Bilbao, Spain.
Förderung
- Universidad de Oviedo
- Universidad de Valladolid
Zitieren
APA
Sanchez, I., Martin-Gonzalez, S., & Portela-Camino, J. A. (2025). Successful persistent strabismic amblyopia treatment using active therapy as an adjuvant to occlusion. Journal of Optometry. https://doi.org/10.1016/j.optom.2025.100557
Vancouver
Sanchez I, Martin-Gonzalez S, Portela-Camino JA. Successful persistent strabismic amblyopia treatment using active therapy as an adjuvant to occlusion. Journal of Optometry. 2025. doi:10.1016/j.optom.2025.100557
BibTeX
@article{Sanchez2025,
author = {Sanchez, Irene and Martin-Gonzalez, Santiago and Portela-Camino, Juan Antonio},
title = {Successful persistent strabismic amblyopia treatment using active therapy as an adjuvant to occlusion},
journal = {Journal of Optometry},
year = {2025},
doi = {10.1016/j.optom.2025.100557}
}
EUVIMED